Trial intelligence / Profile preview

Huatuo Zaizao Pill for motor function and cerebral hemodynamics in convalescent ischemic stroke

ChiCTR2000039756Phase 4Recruiting

Sponsor
Xiyuan Hospital
Start
Dec 2020
Countries
1
01

Overview

Phase 4, open-label trial of Huatuo Zaizao in ischemic stroke and atherothrombotic stroke (2 arms), sponsored by Xiyuan Hospital. Primary endpoints: NIHSS score, ADL score and 9 more. Started Dec 2020; status: recruiting.

02

Drugs

Huatuo Zaizao
03

Conditions

ischemic strokeatherothrombotic stroke

Beyond the preview

Go deeper on ChiCTR2000039756.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000039756.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call